ACH04 to Assess the Safety and Tolerability in Healthy Adults Subjects

Summary

This study intends to provide information on the safety and tolerability of repeated oral doses of ACH04. A phase I, single-center, first in human, open-label, dose escalation study of ACH04 to assess the safety and tolerability in healthy adults subjects is selected to best address the study goals.

Timeline

Start

2013-01

Primary completion

2014-09

Completion

2014-09

Drugs

Indications